Pfizer (NYSE:PFE) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over the past year. The ...

U.S. stock indexes slipped and gave back some of their rallies from the day before, while oil prices got back to rising. The S&P 500 fell 0.4% Tuesday after yo-yoing through the day. The Dow ...

Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which ...

Pfizer (NYSE: PFE) stock hasn't made for a good investment over the past five years. It has declined by 25% in value over ...

Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...

An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday, however the latter firm's shares fell because the clinical trial did not re ...

Pfizer and its partner plan to seek regulatory approval for a Lyme disease vaccine. Pharmaceutical giant Pfizer and French ...

Healthcare dividend stocks are selling off with the turbulence in the Middle East. But, why? The best plays here are ...

Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ("Tutanota") to purchase up to 1 million shares of Pfizer common stock at a ...

Pfizer (PFE 1.60%) and Moderna (MRNA 1.89%) were both leaders in the coronavirus vaccine market. However, as sales of these ...

Serina Therapeutics (SER) stock jumped 39% after-hours on news of a $30M private placement and Greg Bailey's appointment as ...